Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Goodwill (2020 - 2025)

Historic Goodwill for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $7.2 million.

  • Oncology Institute's Goodwill changed 0.0% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $7.2 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Oncology Institute's Goodwill stood at $7.2 million, which was down 0.0% from $7.2 million recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Goodwill registered a high of $34.5 million during Q2 2022, and its lowest value of $4.6 million during Q1 2023.
  • For the 5-year period, Oncology Institute's Goodwill averaged around $13.6 million, with its median value being $7.2 million (2023).
  • Its Goodwill has fluctuated over the past 5 years, first surged by 8715.12% in 2021, then plummeted by 8290.77% in 2023.
  • Quarter analysis of 5 years shows Oncology Institute's Goodwill stood at $26.6 million in 2021, then dropped by 19.56% to $21.4 million in 2022, then tumbled by 66.24% to $7.2 million in 2023, then changed by 0.0% to $7.2 million in 2024, then changed by 0.0% to $7.2 million in 2025.
  • Its Goodwill was $7.2 million in Q3 2025, compared to $7.2 million in Q2 2025 and $7.2 million in Q1 2025.